Compare Dominion Energy Inc (D) vs Johnson & Johnson (JNJ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dominion Energy Inc vs Johnson & Johnson — how do they compare? Dominion Energy Inc trades at $61.75 (market cap $54.12B), while Johnson & Johnson trades at $256.46 (market cap $622.84B). The key difference: Johnson & Johnson is far larger — about 11.5× Dominion Energy Inc's market cap, and Dominion Energy Inc pays the higher dividend (4.34%). Which is the better fit depends on your goals — on Pluang, investors hold Dominion Energy Inc for 76 Days and Johnson & Johnson for 129 Days on average.
| D | JNJ | |
|---|---|---|
Market Cap | $54.12B | $622.84B |
Volume | 4,249,753 | 5,277,426 |
Sector | Utilities | Health |
52-Week High | $71.67 | $278.43 |
52-Week Low | $57.08 | $186.00 |
Typical Hold Time | 76 Days | 129 Days |
Enterprise Value | $108.24B | $651.12B |
Dividend Yield | 4.34% | 2.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dominion Energy (D) trades at $61.53, down 0.76% on the day, with a bearish technical signal driven by moving averages and ADX. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending, and maintains solid profitability with a net income margin of 13.99%. Recent news highlights a proposed merger with NextEra Energy, which could reshape its strategic direction.
The stock offers a consensus price target of $71.56, implying potential upside, supported by a dividend yield. Key risks include execution of the merger, high debt levels, and interest rate sensitivity. Analyst sentiment is mixed with a Hold majority, reflecting cautious optimism amid transformative corporate actions.
Johnson & Johnson (JNJ) trades at $258.45, up 1.44% today, with a bearish technical signal but strong fundamentals including a 21.48% net income margin and consistent earnings beats. The stock is supported by a diversified healthcare portfolio and a recent dividend declaration of $1.34 payable in September 2026. Revenue growth is projected to reach $97.9B in 2026, though net income is expected to moderate. Analyst consensus is bullish with a $286.53 price target, but technical indicators show resistance near $260.
JNJ presents a solid long-term investment opportunity due to its robust profitability, high ROE of 25.74%, and defensive sector positioning. Risks include increasing debt-to-asset ratio (24.06% in 2025) and competitive pressures in pharmaceuticals. The stock's current valuation at a P/E of 29.98 may limit near-term upside, but analyst optimism and dividend reliability support a positive outlook for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dominion Energy Inc
Based in Richmond, Virginia, Dominion Energy is an integrated energy company with over 30 gigawatts of electric generation capacity and more than 90,000 miles of electric transmission and distribution lines. Dominion owns a liquefied natural gas export facility in Maryland and is constructing a 5.2 GW wind farm off the Virginia Beach coast.
Read more on D →About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →
